Zenon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 23-10-2024
- Paid Up Capital ₹ 2.71 M
as on 23-10-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.00 M
as on 23-10-2024
- Revenue -0.98%
(FY 2023)
- Profit 4.53%
(FY 2023)
- Ebitda 5.49%
(FY 2023)
- Net Worth 20.96%
(FY 2023)
- Total Assets 18.58%
(FY 2023)
About Zenon Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.71 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arun Tulsiyan, Panna Tulsyan, and Abhishek Tulsyan serve as directors at the Company.
- CIN/LLPIN
U24231GJ2002PLC040973
- Company No.
040973
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zenon Healthcare Limited offer?
Zenon Healthcare Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Zenon Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Tulsiyan  | Managing Director | 18-Jul-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Tulsyan | Whole-Time Director | 10-Aug-2017 | Current |
| Panna Tulsyan | Director | 18-Jul-2002 | Current |
Financial Performance of Zenon Healthcare.
Zenon Healthcare Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.98% decrease. The company also saw a slight improvement in profitability, with a 4.53% increase in profit. The company's net worth Soared by an impressive increase of 20.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenon Healthcare?
In 2023, Zenon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 21 Sep 2006 | ₹3.00 M | Satisfied |
How Many Employees Work at Zenon Healthcare?
Unlock and access historical data on people associated with Zenon Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
